文献速递皮肤肿瘤

类固醇受体RNA激活因子(SRA)通过激活p38促进上皮-间质转化并介导实验性黑色素瘤转移

Steroid Receptor RNA Activator, a Long Noncoding RNA, Activates p38, Facilitates Epithelial-Mesenchymal Transformation, and Mediates Experimental Melanoma Metastasis.
PubMed 文献 · J Invest Dermatol · 2020-01-13

该研究探讨长链非编码RNA SRA在黑色素瘤转移中的作用。通过RNA干扰敲低B16和A375细胞中SRA,检测增殖、迁移、侵袭、上皮-间质转化(EMT)及体内肺转移。结果显示SRA在黑色素瘤组织中表达升高,敲低后抑制增殖、迁移、侵袭和EMT,并减少肺转移结节,机制涉及p38去磷酸化及B-Raf/MAPK激酶磷酸化改变。

要点

  • SRA在黑色素瘤组织中表达升高,提示其参与疾病进展。
  • 敲低SRA可抑制黑色素瘤细胞增殖、迁移和CCL21介导的侵袭。
  • SRA通过激活p38和调控EMT促进黑色素瘤远处转移。

核心结论

  • SRA在黑色素瘤组织中表达增加,并通过介导p38激活、细胞侵袭和增殖、调控EMT及远处转移参与黑色素瘤进展。

研究设计与样本

  • 采用RNA干扰技术敲低SRA,在B16小鼠黑色素瘤细胞和A375人黑色素瘤细胞中研究其功能。
  • 通过免疫荧光和PCR检测SRAP在黑色素瘤组织及人和小鼠B16黑色素瘤细胞中的表达。
  • 进行体外增殖、迁移、Transwell侵袭实验及体内实验性转移实验评估SRA对黑色素瘤转移的影响。

主要发现

  • SRA敲低显著降低B16细胞和A375细胞的增殖,并显著抑制B16细胞迁移。
  • SRA缺失的B16细胞中CCL21介导的侵袭被消除。
  • B16-SRA抑制细胞中出现p38去磷酸化以及B-Raf和丝裂原活化蛋白激酶激酶1/2的相互磷酸化。
  • CCL21诱导的EMT标志物β-catenin和N-cadherin在B16-SRA抑制细胞中减少。
  • 体内实验性转移显示B16-SRA抑制细胞在肉眼和显微镜下形成的肺部肿瘤结节显著减少。

临床怎么用

  • SRA可能作为黑色素瘤转移的潜在干预靶点,但需进一步临床验证。
  • 检测SRA表达或可辅助评估黑色素瘤转移风险,但目前尚不成熟。

局限性

  • 研究主要基于细胞和动物实验,缺乏临床样本验证。
  • SRA调控黑色素瘤转移的具体分子网络仍需深入阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Melanoma metastasis signals dismal prognosis even with current checkpoint inhibitors. Long noncoding RNAs (lncRNAs) regulate dynamic metastasis in several cancers, including melanoma. We became interested in a lncRNA, steroid receptor RNA activator (SRA), because it is the first lncRNA also encoding a conserved protein, SRAP, and it regulates progression of prostate and breast cancers. We investigated how SRA mediates melanoma proliferation, migration, invasion, epithelial-mesenchymal transformation (EMT), and metastasis by RNA interference. The expression of SRAP was measured in melanoma tissue and in human and mouse B16 melanoma cells by immunofluorescence and PCR. The results showed that SRA knockdown decreased B16 cell and A375 cell proliferation and inhibited B16 cell migration significantly. Transwell analysis revealed that CCL21-mediated invasion was abolished in SRA-deficient B16 cells. In parallel, p38 dephosphorylation and reciprocal phosphorylation of B-Raf and mitogen-activated protein kinase kinase 1/2 were present in B16-SRA inhibited cells. The induction of EMT markers, β-catenin and N-cadherin, by CCL21 was reduced in B16-SRA inhibited cells, suggesting that SRA promotes the EMT process. In vivo experimental metastasis showed that B16-SRA inhibited cells formed significantly fewer tumor nodules in the lungs grossly and microscopically. In summary, our results showed that SRA expression is increased in melanoma tissue and that SRA mediates p38 activation, cell invasion, and proliferation and regulates EMT and distant metastasis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Hong CH, Ho JC, Lee CH, et al. Steroid Receptor RNA Activator, a Long Noncoding RNA, Activates p38, Facilitates Epithelial-Mesenchymal Transformation, and Mediates Experimental Melanoma Metastasis. J Invest Dermatol. 2020. PMID: 31945347. doi:10.1016/j.jid.2019.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。